Invention Grant
- Patent Title: Pharmaceutical composition, use of mefloquine in fixed dose, and method for treating tuberculosis
-
Application No.: US15771941Application Date: 2016-10-07
-
Publication No.: US10688088B2Publication Date: 2020-06-23
- Inventor: Marcus Vinicius Nora De Souza , Raoni Schroeder Borges Goncalves , Maria Cristina Da Silva Lourenco
- Applicant: FUNDACÃO OSWALDO CRUZ
- Applicant Address: BR Rio de Janiero
- Assignee: Fundacao Oswaldo Cruz
- Current Assignee: Fundacao Oswaldo Cruz
- Current Assignee Address: BR Rio de Janiero
- Agency: Dorsey & Whitney LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@647a417e
- International Application: PCT/BR2016/050254 WO 20161007
- International Announcement: WO2017/070763 WO 20170504
- Main IPC: A61K31/4709
- IPC: A61K31/4709 ; A61K31/4409 ; A61K31/4965 ; A61K31/5377 ; A61K31/7036 ; A61K31/133 ; A61K31/496 ; A61P31/06 ; A61K47/02 ; A61K47/10 ; A61K47/20 ; A61K47/26 ; A61K47/32 ; A61K47/38 ; A61K47/44 ; A61K9/10 ; A61K9/00 ; A61K31/42 ; A61K31/513 ; A61K31/606
Abstract:
This invention concerns the use of mefloquine in relation to Mycobacterium tuberculosis. This invention also concerns the combination of mefloquine with drugs used in first and second choice treatment of tuberculosis, achieving a reduction in the treatment period of tuberculosis (TB) and the treatment of multi-drug resistant tuberculosis (MDR-TB).
Public/Granted literature
- US20180318283A1 PHARMACEUTICAL COMPOSITION, USE OF MEFLOQUINE IN A FIXED DOSE, AND METHOD FOR TREATING TUBERCULOSIS Public/Granted day:2018-11-08
Information query
IPC分类:
